Business ❯ Pharmaceuticals

Corporate Governance

Legal Issues Investigations Mergers and Acquisitions Executive Changes Ethics Leadership Changes Investor Relations Executive Misconduct Glenmark Pharmaceuticals Legal Liability Executive Actions Supply Chain Management Shareholder Relations Family Business Litigation Board Leadership Executive Roles Board of Directors Executive Resignation Executive Management Contract Management Regulatory Compliance Activism Management Executive Leadership Investment Fraud Investigation

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

The Indiana case cites regulatory disclosures following company claims about drug progress.

Novo Nordisk Foundation Installs Lars Rebien Sørensen as Chair After Shareholder Vote

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

GSK Taps Luke Miels as Next CEO Starting Jan. 1, 2026